ACRF was founded in 1984 by the late Sir Peter Abeles and the late Lady Sonia McMahon. After surveying several scientists and medical professionals, asking what they needed most to progress cancer research in Australia, they identified a primary need for physical buildings in which to conduct research activities and so determined the focus for The Foundation. As the research landscape has evolved, so has the areas of funding for ACRF. Nowadays, ACRF grants cover technology, equipment, and infrastructure – both physical and virtual.
1 in 3 Australians will be diagnosed with cancer in their lifetime. The remaining 2 will be closely affected by a diagnosis.
At Australian Cancer Research Foundation, we know that only brilliant ideas can tackle something as big as cancer. That is why we give scientists the technology, equipment and infrastructure they need for pioneering research. By funding research that seeks to progress and transform the way we prevent, detect and treat ALL cancers, we are committed to our vision of one day reaching a world without cancer.
Since 1984, thanks to our generous supporters, we’ve awarded 78 grants totalling over $165 million to 42 research institutions across Australia. Supporting ACRF means you are backing projects that push boundaries and blaze new trails. Because we know only brilliant ideas can tackle something as big as cancer.
The Foundation is overseen by an eminent Board of Trustees, with research programs recommended by a highly esteemed Medical Research Advisory Committee (MRAC) comprising scientific and clinical professionals of international repute. ACRF’s MRAC only endorses the most promising projects that have potential to provide us with the greatest health and social returns.
Cancer and the crab have been linked since the early days of medicine. The origin of the word cancer has been linked to the Greek physician Hippocrates (460 – 370 BCE), who is widely considered to be the “Father of Medicine”. Hippocrates used the term ‘karcinos’ (the word for crab) to describe a tumour, because the blood vessels which surround a tumour are crab-like in shape.
The Roman physician, Celsus (28-50 BCE) later translated the Greek term into cancer – the latin word for crab – while another Roman physician, Galen (130 – 200 CE Common Era) used the word ‘oncos’ (Greek for swelling) to describe tumours.
Although the crab analogy of Hippocrates and Celsus is still used to describe malignant tumors (eg. carcinoma), Galen’s term is now used to refer to the specialist study of cancer, oncology.
The Late Sir Peter Abeles AC
April 1924 – June 1999
Named ‘Australian of the Year’ by ‘The Australian’ in 1987, Sir Peter Abeles established the Australian Cancer Research Foundation in 1984.
The Late Lady [Sonia] McMahon
August 1932 – April 2010
A founding trustee and life member, Lady McMahon had a very significant impact on the Foundation and its mission to fund Australian cancer research projects at the forefront of medical science.
The Late Mr John Boettcher OAM
September 1931 – September 2012
Mr Boettcher was an unwavering enthusiast for ACRF’s work, and a significant part of our growth and achievements. He was a much-loved and highly respected member of the ACRF team.
The Late Sir Ian Turbott AO CMG CVO
March 1922 – August 2016
Sir Ian Turbott was chairman of the I T Graham Investments Pty Limited, director of the Australian Youth Trust (established by the Commonwealth Day Council NSW), director of the Ted Noffs Foundation and Emeritus Chancellor of the University of Western Sydney.
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialed for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.
